个人中心 - 老虎社区

闪亮ing

IP属地：未知

帖子 · 10帖子 · 10
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 闪亮ing闪亮ing
  ·2020-02-10
  这篇文章不错，转发给大家看
  VTV Therapeutics盘前暴涨85%，今日公布药物数据
  2月10日美股盘前，生物制药公司VTV Therapeutics$(VTVT)$暴涨85%。该公司周五表示，周一上午将公布第二期Simplici-T1试验第二部分的最新结果，该试验评估TTP399
  VTV Therapeutics盘前暴涨85%，今日公布药物数据
  922 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-06-19
  $Melinta Therapeutics, Inc.(MLNT)$ 有水平的庄
  1,309 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-08
  $Tonix Pharmaceuticals Holding Co(TNXP)$ 不容易啊，总算加码速度了
  1,333 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-08
  $Tonix Pharmaceuticals Holding Co(TNXP)$ 今天的股确实有点邪乎，考虑再三，还是选你吧
  1,018 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-08
  $Tonix Pharmaceuticals Holding Co(TNXP)$ 果断上
  1,262 2
  1
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-08
  $GTx(GTXI)$ 后发制人还是很有意思
  1,770 1
  1
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-07
  $GTx(GTXI)$ 慢工出细活
  897 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2019-03-07
  $GTx(GTXI)$ 后半场发力
  735 评论
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2018-10-05
  $GTx(GTXI)$ 感觉今晚还能起来
  840 2
  点赞
  分享
  举报
- 闪亮ing闪亮ing
  ·2018-09-22
  $India Globalization Capital(IGC)$ 看这趋势明天还得走一波
  1,167 1
  点赞
  分享
  举报
暂无粉丝

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3475211484743050","uuid":"3475211484743050","gmtCreate":1512117464446,"gmtModify":1512117464446,"name":"闪亮ing","pinyin":"slingshanlianging","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":64,"tweetSize":10,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":965,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":914297661,"gmtCreate":1581345203253,"gmtModify":1704343876854,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/914297661","repostId":"1157125422","repostType":2,"repost":{"id":"1157125422","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1581340360,"share":"https://www.laohu8.com/m/news/1157125422?lang=&edition=full","pubTime":"2020-02-10 21:12","market":"us","language":"zh","title":"VTV Therapeutics盘前暴涨85%，今日公布药物数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1157125422","media":"老虎资讯综合","summary":"2月10日美股盘前，生物制药公司VTV Therapeutics$(VTVT)$暴涨85%。\n\n该公司周五表示，周一上午将公布第二期Simplici-T1试验第二部分的最新结果，该试验评估TTP399","content":"<p><span>2月10日美股盘前，生物制药公司VTV Therapeutics<a href=\"https://laohu8.com/S/VTVT\">$(VTVT)$</a>暴涨85%。</span></p>\n<p><img src=\"https://static.tigerbbs.com/b33f76b37c8eb11741cc9b945b2feaad\"></p>\n<p><span>该公司周五表示，周一上午将公布第二期Simplici-T1试验第二部分的最新结果，该试验评估TTP399为成人1型糖尿病患者胰岛素的口服辅助疗法。</span></p>\n<p><span>在2019年6月，该公司宣布了第二阶段研究的第一部分的积极结果，该部分显示HbA1c在统计学上显著下降，而没有增加酮症酸中毒或低血糖。在第一部分中，TTP 399的耐受性与治疗相似--总体上和系统器官类紧急不良事件的发生率相似。第一部分无严重不良事件报告，无糖尿病酮症酸中毒或严重低血糖的报告。</span></p>\n<p><span><b>关于TTP399。</b></span><span>葡萄糖激酶(GK)是葡萄糖代谢的关键调节因子，它的激活可以增加葡萄糖的利用率，进而降低血糖。TTP399是一种口服的GK激动剂，旨在通过仅针对肝脏中的GK激活来实现血糖控制，其作用机制不依赖于胰岛素。</span></p>\n<p><span>到目前为止，TTP399已经在12项临床试验中进行了研究，其中包括一项针对2型糖尿病患者的为期6个月的2b期试验，在该试验中，它显示出HbA1c持续、有意义的降低，耐受性良好，低血糖和高脂血症的发生率可以忽略不计，没有糖尿病酮症酸中毒的发生。</span></p>\n<p><span><b>关于Simplici-T1。</b></span><span>Simplici-T1是一项多中心、随机、双盲、适应性研究，评估TTP399作为成人T1D胰岛素治疗辅助药物的安全性和有效性。主要终点是第12周时HbA1c的变化。这项研究是在JDRF的支持下进行的，JDRF是资助1型糖尿病研究的领先全球组织。这项第二阶段的学习和确认研究在相同的方案下分两部分进行，以评估TTP399在经过多周胰岛素优化和安慰剂磨合期后每天给药12周以上的T1D患者的安全性和有效性。第一部分招募了19名同时接受胰岛素泵和CGMS治疗的患者。第二阶段-第一部分的阳性背线结果于2019年6月报告。第二部分招募了85名患者，他们使用胰岛素泵或每天多次注射胰岛素，没有使用CGM。</span></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>VTV Therapeutics盘前暴涨85%，今日公布药物数据</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVTV Therapeutics盘前暴涨85%，今日公布药物数据\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-02-10 21:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>2月10日美股盘前，生物制药公司VTV Therapeutics<a href=\"https://laohu8.com/S/VTVT\">$(VTVT)$</a>暴涨85%。</span></p>\n<p><img src=\"https://static.tigerbbs.com/b33f76b37c8eb11741cc9b945b2feaad\"></p>\n<p><span>该公司周五表示，周一上午将公布第二期Simplici-T1试验第二部分的最新结果，该试验评估TTP399为成人1型糖尿病患者胰岛素的口服辅助疗法。</span></p>\n<p><span>在2019年6月，该公司宣布了第二阶段研究的第一部分的积极结果，该部分显示HbA1c在统计学上显著下降，而没有增加酮症酸中毒或低血糖。在第一部分中，TTP 399的耐受性与治疗相似--总体上和系统器官类紧急不良事件的发生率相似。第一部分无严重不良事件报告，无糖尿病酮症酸中毒或严重低血糖的报告。</span></p>\n<p><span><b>关于TTP399。</b></span><span>葡萄糖激酶(GK)是葡萄糖代谢的关键调节因子，它的激活可以增加葡萄糖的利用率，进而降低血糖。TTP399是一种口服的GK激动剂，旨在通过仅针对肝脏中的GK激活来实现血糖控制，其作用机制不依赖于胰岛素。</span></p>\n<p><span>到目前为止，TTP399已经在12项临床试验中进行了研究，其中包括一项针对2型糖尿病患者的为期6个月的2b期试验，在该试验中，它显示出HbA1c持续、有意义的降低，耐受性良好，低血糖和高脂血症的发生率可以忽略不计，没有糖尿病酮症酸中毒的发生。</span></p>\n<p><span><b>关于Simplici-T1。</b></span><span>Simplici-T1是一项多中心、随机、双盲、适应性研究，评估TTP399作为成人T1D胰岛素治疗辅助药物的安全性和有效性。主要终点是第12周时HbA1c的变化。这项研究是在JDRF的支持下进行的，JDRF是资助1型糖尿病研究的领先全球组织。这项第二阶段的学习和确认研究在相同的方案下分两部分进行，以评估TTP399在经过多周胰岛素优化和安慰剂磨合期后每天给药12周以上的T1D患者的安全性和有效性。第一部分招募了19名同时接受胰岛素泵和CGMS治疗的患者。第二阶段-第一部分的阳性背线结果于2019年6月报告。第二部分招募了85名患者，他们使用胰岛素泵或每天多次注射胰岛素，没有使用CGM。</span></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","relate_stocks":{"VTVT":"vTv Therapeutics Inc."},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157125422","content_text":"2月10日美股盘前，生物制药公司VTV Therapeutics$(VTVT)$暴涨85%。\n\n该公司周五表示，周一上午将公布第二期Simplici-T1试验第二部分的最新结果，该试验评估TTP399为成人1型糖尿病患者胰岛素的口服辅助疗法。\n在2019年6月，该公司宣布了第二阶段研究的第一部分的积极结果，该部分显示HbA1c在统计学上显著下降，而没有增加酮症酸中毒或低血糖。在第一部分中，TTP 399的耐受性与治疗相似--总体上和系统器官类紧急不良事件的发生率相似。第一部分无严重不良事件报告，无糖尿病酮症酸中毒或严重低血糖的报告。\n关于TTP399。葡萄糖激酶(GK)是葡萄糖代谢的关键调节因子，它的激活可以增加葡萄糖的利用率，进而降低血糖。TTP399是一种口服的GK激动剂，旨在通过仅针对肝脏中的GK激活来实现血糖控制，其作用机制不依赖于胰岛素。\n到目前为止，TTP399已经在12项临床试验中进行了研究，其中包括一项针对2型糖尿病患者的为期6个月的2b期试验，在该试验中，它显示出HbA1c持续、有意义的降低，耐受性良好，低血糖和高脂血症的发生率可以忽略不计，没有糖尿病酮症酸中毒的发生。\n关于Simplici-T1。Simplici-T1是一项多中心、随机、双盲、适应性研究，评估TTP399作为成人T1D胰岛素治疗辅助药物的安全性和有效性。主要终点是第12周时HbA1c的变化。这项研究是在JDRF的支持下进行的，JDRF是资助1型糖尿病研究的领先全球组织。这项第二阶段的学习和确认研究在相同的方案下分两部分进行，以评估TTP399在经过多周胰岛素优化和安慰剂磨合期后每天给药12周以上的T1D患者的安全性和有效性。第一部分招募了19名同时接受胰岛素泵和CGMS治疗的患者。第二阶段-第一部分的阳性背线结果于2019年6月报告。第二部分招募了85名患者，他们使用胰岛素泵或每天多次注射胰岛素，没有使用CGM。","news_type":1},"isVote":1,"tweetType":1,"viewCount":922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":904892506,"gmtCreate":1560954033205,"gmtModify":1704701109957,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$Melinta Therapeutics, Inc.(MLNT)$ 有水平的庄","listText":"$Melinta Therapeutics, Inc.(MLNT)$ 有水平的庄","text":"$Melinta Therapeutics, Inc.(MLNT)$ 有水平的庄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/904892506","isVote":1,"tweetType":1,"viewCount":1309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":421820,"gmtCreate":1552060373879,"gmtModify":1704792124353,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 不容易啊，总算加码速度了","listText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 不容易啊，总算加码速度了","text":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 不容易啊，总算加码速度了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/421820","isVote":1,"tweetType":1,"viewCount":1333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":421677,"gmtCreate":1552058538704,"gmtModify":1704792106439,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 今天的股确实有点邪乎，考虑再三，还是选你吧","listText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 今天的股确实有点邪乎，考虑再三，还是选你吧","text":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 今天的股确实有点邪乎，考虑再三，还是选你吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/421677","isVote":1,"tweetType":1,"viewCount":1018,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":421665,"gmtCreate":1552058387243,"gmtModify":1704792104736,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 果断上","listText":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 果断上","text":"$Tonix Pharmaceuticals Holding Co(TNXP)$ 果断上","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/421665","isVote":1,"tweetType":1,"viewCount":1262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":420173,"gmtCreate":1551976465670,"gmtModify":1704791930310,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$GTx(GTXI)$ 后发制人还是很有意思","listText":"$GTx(GTXI)$ 后发制人还是很有意思","text":"$GTx(GTXI)$ 后发制人还是很有意思","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/420173","isVote":1,"tweetType":1,"viewCount":1770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":419946,"gmtCreate":1551973902077,"gmtModify":1704791904733,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$GTx(GTXI)$ 慢工出细活","listText":"$GTx(GTXI)$ 慢工出细活","text":"$GTx(GTXI)$ 慢工出细活","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/419946","isVote":1,"tweetType":1,"viewCount":897,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":419919,"gmtCreate":1551973442120,"gmtModify":1704791901771,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$GTx(GTXI)$ 后半场发力","listText":"$GTx(GTXI)$ 后半场发力","text":"$GTx(GTXI)$ 后半场发力","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/419919","isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":290231,"gmtCreate":1538752614972,"gmtModify":1704776296486,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$GTx(GTXI)$ 感觉今晚还能起来","listText":"$GTx(GTXI)$ 感觉今晚还能起来","text":"$GTx(GTXI)$ 感觉今晚还能起来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/290231","isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3499254177020776","authorId":"3499254177020776","name":"msker","avatar":"https://static.tigerbbs.com/e0d9fd71c4e8f819e62d96fdb62ad697","crmLevel":1,"crmLevelSwitch":0,"idStr":"3499254177020776","authorIdStr":"3499254177020776"},"content":"今晚肯定会起来的，甚至会到2.5左右","text":"今晚肯定会起来的，甚至会到2.5左右","html":"今晚肯定会起来的，甚至会到2.5左右"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":276270,"gmtCreate":1537553157084,"gmtModify":1704774599873,"author":{"id":"3475211484743050","authorId":"3475211484743050","name":"闪亮ing","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3475211484743050","authorIdStr":"3475211484743050"},"themes":[],"htmlText":"$India Globalization Capital(IGC)$ 看这趋势明天还得走一波","listText":"$India Globalization Capital(IGC)$ 看这趋势明天还得走一波","text":"$India Globalization Capital(IGC)$ 看这趋势明天还得走一波","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/276270","isVote":1,"tweetType":1,"viewCount":1167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}